Cargando…

Development of clinical simultaneous SPECT/MRI

There is increasing clinical use of combined positron emission tomography and MRI, but to date there has been no clinical system developed capable of simultaneous single-photon emission computed tomography (SPECT) and MRI. There has been development of preclinical systems, but there are several chal...

Descripción completa

Detalles Bibliográficos
Autores principales: Hutton, Brian F, Occhipinti, Michele, Kuehne, Andre, Máthé, Domokos, Kovács, Noémi, Waiczies, Helmar, Erlandsson, Kjell, Salvado, Debora, Carminati, Marco, Montagnani, Giovanni L, Short, Susan C, Ottobrini, Luisa, van Mullekom, Pieter, Piemonte, Claudio, Bukki, Tamas, Nyitrai, Zoltan, Papp, Zoltan, Nagy, Kalman, Niendorf, Thoralf, de Francesco, Irene, Fiorini, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Institute of Radiology. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966197/
https://www.ncbi.nlm.nih.gov/pubmed/28008775
http://dx.doi.org/10.1259/bjr.20160690
Descripción
Sumario:There is increasing clinical use of combined positron emission tomography and MRI, but to date there has been no clinical system developed capable of simultaneous single-photon emission computed tomography (SPECT) and MRI. There has been development of preclinical systems, but there are several challenges faced by researchers who are developing a clinical prototype including the need for the system to be compact and stationary with MRI-compatible components. The limited work in this area is described with specific reference to the Integrated SPECT/MRI for Enhanced stratification in Radio-chemo Therapy (INSERT) project, which is at an advanced stage of developing a clinical prototype. Issues of SPECT/MRI compatibility are outlined and the clinical appeal of such a system is discussed, especially in the management of brain tumour treatment.